ASTAGRAF XL Trademark

Trademark Overview

On Tuesday, May 7, 2013, a trademark application was filed for ASTAGRAF XL with the United States Patent and Trademark Office. The USPTO has given the ASTAGRAF XL trademark a serial number of 85925271. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, December 18, 2019. This trademark is owned by Astellas Pharma Inc.. The ASTAGRAF XL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, immunotherapy preparations
astagraf xl

General Information

Serial Number85925271
Word MarkASTAGRAF XL
Filing DateTuesday, May 7, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, December 18, 2019
Registration Number4480263
Registration DateTuesday, February 11, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2013

Trademark Statements

Goods and ServicesPharmaceuticals, namely, immunotherapy preparations
Disclaimer with Predetermined Text"XL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 14, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChuo-ku, Tokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChuo-ku, Tokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChuo-ku, Tokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Thursday, January 18, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, February 11, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 18, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, December 18, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 18, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 8, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, February 11, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 11, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 11, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2013ASSIGNED TO LIE
Tuesday, October 8, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 27, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 27, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, August 27, 2013SUSPENSION LETTER WRITTEN
Monday, August 26, 2013ASSIGNED TO EXAMINER
Tuesday, May 14, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 10, 2013NEW APPLICATION ENTERED

Related Keywords

astagraf preparations immunotherapy namely pharmaceuticals